Medtronic has opened its new manufacturing facility, Medtronic Singapore Operations (MSO), to meet the future expected growth of cardiac devices in Asia.
As of November 2011, Singapore will also serve as the distribution hub for the Asia-Pacific region.
The new facility, which began operations in January 2011, will enable Medtronic to respond more effectively and efficiently to the needs of customers and patients with cardiac rhythm disorders, improving standards of care in Asia.
In addition to the manufacturing facility, MSO will also serve as the Asia headquarters, International headquarters and ASEAN headquarters as well as the center for Singapore sales operations.
The Singapore-based office will also house the heads of departments leading the Manufacturing team, International Leadership team, ASEAN Leadership team and Emerging Countries Business Development team.
The Medtronic Singapore Operations is added on to Medtronic’s stable of more than 250 manufacturing facilities, sales offices, research centres, education centres and administration facilities which serve customers and patients in 120 countries.